How CRI-Funded Scientists are Reducing and Guarding Against Childhood Cancers September 15, 2023September 15, 2023 Max Mallet
Dr. Jill O’Donnell-Tormey on the State of Cancer Immunotherapy and the Contributions CRI Continues to Make to the Field September 12, 2023September 13, 2023 CRI Staff
AACR 2023 Recap: CRI Scientists Tackle the Frontiers of Cancer Immunotherapy April 20, 2023April 20, 2023 Arthur N. Brodsky, PhD
A Conversation with CRI ImmunoAdvocate Karen Peterson February 23, 2023February 23, 2023 Arthur N. Brodsky, PhD
The IO Clinical Trial Gap in the Black Patient Population: It’s Time to Sound the Alarm February 8, 2023February 15, 2023 Karen Peterson